Anti-ccr8 antibodies
AssigneeMonash University
InventorRemy Michel ROBERT
Life of this patent
Estimating the term…
Abstract
The invention relates to antigen binding proteins and related fragments thereof for binding to CCR8, to production of said antigen binding proteins and fragments and to use of said antigen binding proteins and fragments for detection and therapy of various conditions.
Claims39
An antigen binding protein that binds to or specifically binds to the extracellular loop 2 of CCR8.
An antigen binding protein comprising a CDRH1, a CDRH2 and/or a CDRH3 of an antibody having a variable heavy chain as defined in SEQ ID NO:
- 1 and a CDRL1, a CDRL2 and/or a CDRL3 of an antibody having a variable light chain as defined in SEQ ID NO:
- 2.
An antigen binding protein that binds to or specifically binds to CCR8 and wherein the antigen binding protein competitively inhibits the binding of an antibody comprising:
- a VH comprising a sequence as set forth in SEQ ID NO:
- 1 and a VL comprising a sequence as set forth in SEQ ID NO:
- 2;
- or a VH comprising a sequence as set forth in SEQ ID NO:
- 83 and a VL comprising a sequence as set forth in SEQ ID NO:
- 84.
An anti-CCR8 antibody or antigen binding fragment thereof comprising a light chain variable region and a heavy chain variable region,
- wherein said heavy chain variable region comprises:
- a CDR H1 as set forth in SEQ ID NO:
- 5, a CDR H2 as set forth in SEQ ID NO:
- 6, and a CDR H3 as set forth in SEQ ID NO:
- 7;
- and
- wherein said light chain variable region comprises:
- a CDR L1 as set forth in SEQ ID NO:
- 8, a CDR L2 as set forth in SEQ ID NO:
- 9 and a CDR L3 as set forth in SEQ ID NO:
- 10.
An anti-CCR8 antibody or antigen binding fragment thereof, comprising a light chain variable region and a heavy chain variable region,
- wherein said heavy chain variable region comprises:
- a CDR H1 as set forth in SEQ ID NO:
- 19, a CDR H2 as set forth in SEQ ID NO:
- 20, and a CDR H3 as set forth in SEQ ID NO:
- 21;
- and
- wherein said light chain variable region comprises:
- a CDR L1 as set forth in SEQ ID NO:
- 22, a CDR L2 as set forth in SEQ ID NO:
- 23 and a CDR L3 as set forth in SEQ ID NO:
- 10.
Dependencies are inferred from the claim text.